Euro vs US Dollar

Überwachen Sie mehrere Echtzeitkurse von führenden Börsen wie NASDAQ, NYSE, AMEX, Bovespa und mehr.

Registrieren

SILO Silo Pharma Inc

0,9899

0,0399 (4,20%)

04 Jan 2025 - Geschlossen

Verzögert um 15 Minuten

Form S-1 - General form for registration of securities under the Securities Act of 1933

Article too big to display. Click here to view on the SEC website

Silo Pharma (NASDAQ:SILO)
Historical Stock Chart
Von Dez 2024 bis Jan 2025

Click Here for more Silo Pharma Charts.

Silo Pharma (NASDAQ:SILO)
Historical Stock Chart
Von Jan 2024 bis Jan 2025

Click Here for more Silo Pharma Charts.

News Silo Pharma Inc

Form 8-K - Current report
Donnerstag 2 Januar 2025 (3 Tage vor) • Edgar (US Regulatory)

Silo Pharma Issues Letter to Shareholders Detailing Development Progress and Potential for Lead Assets Targeting PTSD and Chronic Pain
Donnerstag 2 Januar 2025 (3 Tage vor) • GlobeNewswire Inc.

Form 8-K - Current report
Freitag 20 Dezember 2024 (2 Wochen vor) • Edgar (US Regulatory)

Silo Pharma Initiates Pharmacokinetic and Tolerability Study for SP-26 Targeting Chronic Pain and Fibromyalgia
Mittwoch 18 Dezember 2024 (3 Wochen vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Montag 16 Dezember 2024 (3 Wochen vor) • Edgar (US Regulatory)

Silo Pharma Enters Joint Development Agreement for SP-26 Ketamine Implant Device Targeting Pain Management
Freitag 29 November 2024 (1 Monat vor) • GlobeNewswire Inc.

Form 4 - Statement of changes in beneficial ownership of securities
Freitag 22 November 2024 (1 Monat vor) • Edgar (US Regulatory)

Silo Pharma Announces Positive Results for Novel SPC-15 Treatment Targeting Stress-Related Disorders
Montag 18 November 2024 (2 Monate vor) • GlobeNewswire Inc.

Form DEFR14A - Revised definitive proxy soliciting materials
Freitag 15 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Dienstag 12 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Freitag 8 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Form 8-K - Current report
Freitag 8 November 2024 (2 Monate vor) • Edgar (US Regulatory)

Weitere Silo Pharma Inc News-Artikel

Deutsche Lufthansa

Energy Select Sector SPDR

BNP Paribas (QX)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen